← Leaderboards
Celestine N Wanjalla
Vanderbilt University Medical Center
$1,642,436
Attributed
$1,642,436
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $935.7K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,642,436 · 2
By mechanism
K23$859,788 · 1
R01$782,648 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- Spyros A Kalams$30,057,725
- Jessica L Castilho$5,935,018
- Alexander Bick$5,781,681
- Matthew Schrag$7,278,640
- Angela L. Jefferson$48,680,773
Others in their field
Other Emerging Leaders on “Phenotype”
- Leonard Freedman · Leidos Biomedical Research, Inc.$68,463,085
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Lynn Briscoe · Leidos Biomedical Research, Inc.$28,580,688
- Evan Z Macosko · Broad Institute, Inc.$28,218,682
- Badri N Vardarajan · University Of Miami School Of Medicine$23,982,327
Research focus
PhenotypeAntiretroviral TherapyImmunePersonsCardiovascular DiseasesInflammationChronicCytomegalovirusLinkPeripheral Blood Mononuclear CellTrainingT-LymphocyteCd4 Positive T LymphocytesMetabolic DiseasesAcquired Immunodeficiency SyndromeCellsCo-InfectionCommunicable DiseasesAntibodiesCardiovascular SystemAnimal ModelAtherosclerosisAdgr1 GeneCareer Development
Grant awards (6)
The Nexus of Trained Immunity and Stable Immune Complexes: Implications for Aging-Related Conditions in PLWH$782,648
R01 · FY2025 · AG · contact PI
Anti-cytomegalovirus Immune Responses in Atherosclerotic Cardiovascular Disease in Persons Living with HIV$153,036
K23 · FY2025 · HL · contact PI
Anti-cytomegalovirus Immune Responses in Atherosclerotic Cardiovascular Disease in Persons Living with HIV$153,036
K23 · FY2024 · HL · contact PI
Anti-cytomegalovirus Immune Responses in Atherosclerotic Cardiovascular Disease in Persons Living with HIV$183,276
K23 · FY2023 · HL · contact PI
Anti-cytomegalovirus Immune Responses in Atherosclerotic Cardiovascular Disease in Persons Living with HIV$185,220
K23 · FY2022 · HL · contact PI
Anti-cytomegalovirus Immune Responses in Atherosclerotic Cardiovascular Disease in Persons Living with HIV$185,220
K23 · FY2021 · HL · contact PI